WebMD Hits a 52-Week Low: Will It Flatline?

Shares of WebMD (Nasdaq: WBMD  ) , the online health care portal, hit a 52-week low yesterday in reaction to a less-than-stellar earnings report. Let's take a look at how the company got here to find out whether the long-term prognosis is terminal.

How it got here
WebMD has been moving lower for a year now, starting with a big drop last summer followed by another plunge in November on weak forward guidance. The pain continued with a virtual stock-price heart attack in January after its efforts to find a buyer ended in embarrassing failure, and last month saw another humiliation as the market all but scoffed at WebMD's efforts to buy back shares. Since announcing its buyback intentions, WebMD's share price has not once reached the $26 high end of its anticipated $150 million buyback.

Despite meeting expectations for first-quarter results, more lousy forward guidance drew another pitiful reaction from investors. It's all added up to send shares to not only 52-week lows, but five-year lows as well:

WBMD Total Return Price Chart

WBMD Total Return Price data by YCharts.

The health information sector has been lousy in general, but WebMD has been among the worst performers, only narrowly beating out Allscripts (Nasdaq: MDRX  ) thanks to a similarly moribund first-quarter earnings report that just wound up looking comparatively worse to the market than WebMD's.

What you need to know
While no company offers quite the breadth of WebMD's vast and regularly updated health information database directed at both consumers and professionals, it's also debatable as to whether or not any one company needs to. As the table below shows, companies that offer health information as an ancillary service have generally outperformed WebMD in the past few years.

Company

P/E Ratio

Annualized 3-Year Earnings Growth

Net Margin (TTM)

WebMD 27.4 (14.0%) 8.9%
Allscripts 30.3 41.4% 4.5%
Aetna (NYSE: AET  ) 8.8 15.9% 5.6%
UnitedHealth (NYSE: UNH  ) 11.6 10.4% 5.0%
Google (Nasdaq: GOOG  ) 18.5 14.3% 27.1%

Source: Yahoo! Finance.

Part of WebMD's more recent underperformance comes from the gradual correcting of what the market saw as too high a valuation. A drastic dip in net income that began two years ago never really reversed, causing investors to lose faith in the company's future:

WBMD Net Income TTM Chart

WBMD Net Income TTM data by YCharts.

Meanwhile, Allscripts offers professional-focused health care information services, Aetna and UnitedHealth both make private health-information portals available to large captive audiences, and even web-information gateway Google has begun making its presence felt in the health information industry. Information on its own doesn't offer much of a moat, and WebMD's responses to the competition haven't earned the trust of many investors -- except, perhaps unsurprisingly, corporate raider Carl Icahn, who recently doubled his stake in the company. His involvement might just be shareholders' best hope for gains in the near future.

What's next?
Where does WebMD go from here? That will depend on whether or not the company can turn its dwindling financial fortunes around, or whether or not Carl Icahn goes all in. The Motley Fool's CAPS community has given WebMD a meager two-star rating, with a third expecting the stock to continue its 52-week trend. The majority hopes for a recovery, but they're not particularly confident about it.

Looking to invest like a billionaire but not sure Icahn's got his eyes on the right prize? Take a look at The Motley Fool's special free report: "The Stocks Only the Smartest Investors are Buying." Beat the 1% at their own game with one under-the-radar outperformer in an elite group of compelling stocks you can buy at great prices today. Click here to get your free information now.

Fool contributor Alex Planes holds no financial position in any company mentioned here. Add him on Google+ or follow him on Twitter @TMFBiggles for more news and insights. The Motley Fool owns shares of Google. Motley Fool newsletter services have recommended buying shares of Google and UnitedHealth Group, as well as creating a diagonal call position in UnitedHealth Group. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1880893, ~/Articles/ArticleHandler.aspx, 9/17/2014 12:15:43 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement